Grace therapeutics to participate in the td cowen 45th annual health care conference

Princeton, n.j., feb. 25, 2025 (globe newswire) -- grace therapeutics, inc. (nasdaq: grce) formerly acasti pharma inc. (grace therapeutics or the company), a late-stage, biopharma company advancing gtx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for iv infusion to address significant unmet medical needs in aneurysmal subarachnoid hemorrhage (asah) patients, today announced that chief executive officer prashant kohli will participate in the upcoming td cowen 45th annual health care conference, to be held in boston, ma, march 3-5, 2025.
COWN Ratings Summary
COWN Quant Ranking